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P
rimary ciliary dyskinesia (PCD; Immotile cilia syndrome;
OMIM 242650) is an autosomal recessive disorder
resulting from dysmotility of cilia and sperm flagella.
1
Cilia and flagella function either to create circulation of fluid
over a stationary cell surface or to propel a cell through
fluid.
23 These related structures are highly complex orga-
nelles composed of over 200 different polypeptides.
45 The
core or axoneme of cilia and flagella comprises a bundle of
microtubules and many associated proteins. The microtu-
bules are formed from a and b tubulin protofilaments and are
arranged in a well recognised ‘9+2’ pattern: nine peripheral
microtubule doublets in a ring connected around a central
pair of microtubules by radial spoke proteins. The peripheral
microtubules have dynein motor proteins attached and are
connected with each other by nexin links.
6–8
In human beings, ciliated epithelium can be found lining
the respiratory tract, including the sinuses and middle ear,
the brain ependyma, the female oviduct, and the male vas
deferens. Cilia in the respiratory tract play an important part
in airway clearance of respiratory secretions. In primary
ciliary dyskinesia, impaired mucociliary clearance causes
recurrent respiratory tract infections including chronic otitis
media, rhinitis, and sinusitus, often leading to permanent
lung damage (bronchiectasis).
9 Patients are also often
subfertile due to sperm tail immotility and immotile oviduct
cilia. About half of the patients have defects of laterality,
usually complete mirror-image reversal of the left-right axis
(situs inversus) and this association is known as Kartagener
syndrome (OMIM 244400). The defects in left-right axis
determination associated with primary ciliary dyskinesia are
proposed to result from dysfunction of the embryonic node
monocilia during development.
10–12
Primary ciliary dyskinesia has an incidence of 1 in 20 000
with enrichment in certain populations.
91 3Diagnosis is made
on brushings or biopsy of nasal epithelium by demonstration
of abnormal ciliary beating, and by demonstration of
ultrastructural defects of cilia by electron microscopy.
14 15
Primary ciliary dyskinesia is a chronic condition with
symptoms present from birth but there is significant
variation both in clinical severity and the age at which the
condition is diagnosed.
91 51 6There is usually a progressively
greater impact on health from the second decade onwards,
producing significant morbidity and life style restriction.
17 In
some cases of severe lung damage, heart-lung transplanta-
tion is required
18 and in general patients greatly benefit from
early diagnosis and management.
16 19
Primary ciliary dyskinesia is a phenotypically heteroge-
neous condition associated with a variety of ultrastructural
abnormalities of the cilia and sperm flagella. These include
absent dynein arms (approximately 70–80% of cases), absent
radial spokes (5–10%), absent central pair microtubules,
other rarer microtubular defects, and random ciliary orienta-
tion.
20–22 Genetic linkage analysis and mutational studies in
patients with primary ciliary dyskinesia have shown that this
disease is genetically heterogeneous, even within groups of
families with the same specific ultrastructural defect.
23–27 An
unusual probable dominant inheritance pattern has also been
reported for the disease.
28 Mutations in genes encoding two
different axonemal outer dynein arm components (DNAI1
and DNAH5) have been shown to cause primary ciliary
dyskinesia in a number of patients with outer dynein arm
defects.
27 29 Defects in another dynein, DNAH11, have been
................................................................
Abbreviation: PCD, primary ciliary dyskinesia
Key points
N Primary ciliary dyskinesia is an autosomal recessive
disorder characterised by recurrent sinopulmonary
infections, bronchiectasis, and subfertility, due to
dysfunction of the cilia. Fifty percent of patients with
primary ciliary dyskinesia have defects of laterality
(situs inversus) and this association is known as
Kartagener syndrome. Primary ciliary dyskinesia has
an estimated incidence of 1 in 20 000 live births.
N To identify loci for this genetically heterogeneous
condition, genome wide linkage scans and subsequent
fine mapping were performed in two different isolated
populations with distinct ciliary ultrastructural defects,
from the Faroe Islands and the Druze community in
northern Israel.
N A locus was mapped in seven families from the Faroe
Islands to a 2.8 cM interval on chromosome 16p12.1-
12.2, with a maximum lod score of 3.15, obtained
using GENEHUNTER. A locus was mapped in three out
of four Druze families from the Golan region of Israel
to a 17 cM region on chromosome 15q13.1-15.1, with
a maximum hlod score of 3.2 at a (proportion of linked
families)=0.7, using GENEHUNTER.
N This study provides further evidence of the genetic
heterogeneity underlying primary ciliary dyskinesia
and has established a framework to facilitate isolation
of two genes for primary ciliary dyskinesia. Deter-
mining the molecular basis of primary ciliary dyskine-
sia will provide insight into the genetic control of cilia
assembly and function and the pathway which
determines the vertebrate left right axis.
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cilia ultrastructure.
26 The exact role of DNAH11 in primary
ciliary dyskinesia has yet to be elucidated. Two other genes
for primary ciliary dyskinesia have been localised: CILD2 to
19q,
23 and another locus to 15q24 (M P Witt, personal
communication).
To identify loci for PCD, genome wide linkage scans and
subsequent fine mapping were performed in two different
isolated populations with distinct ciliary ultrastructural
defects, from the Faroe Islands and the Druze community
in northern Israel.
The Faroes comprise a small group of islands in the North
Atlantic Ocean located near Iceland, Scotland, and Norway
with a relatively young population of mixed Norwegian,
Danish, and British ancestry. The islands were colonised at
the same time as Iceland, around 1100 years ago and the
population size remained small until rapid expansion in the
1800s. The current population size is estimated at 48 000 and
has arisen predominantly by indigenous expansion.
30 31 The
Druze community, a small middle eastern religious sect, was
established slightly later, in the evelenth century AD.
32
Members live predominantly in defined geographical areas
of southern Syria, southern Lebanon, and northern Israel and
they remain isolated mainly for religious reasons. Both
populations are also isolated for geographical and cultural
reasons, in the Faroe Islands associated with limited
immigration
30 31 and in the Druze with a high level of
consanguinity.
33
With relatively few founders, a limited population size, and
recent expansion, the Faroes and Druze populations are
suitable for genetic mapping of a heterogeneous recessive
disease. This has been demonstrated in the Faroe Island
population, in which enrichment of disease incidence
associated with specific gene mutations due to founder
effects has been shown for cystic fibrosis and glycogen
storage disease IIIA.
34 35 Similar findings have been reported
for several conditions in the well studied Druze population
including cystic fibrosis,
36 Krabbe disease
37 and mucoliprido-
sis.
38 However the Druze population has not always proved to
be genetically homogeneous.
39
We report here the identification of two new PCD loci in
these genetic isolates, located on chromosomes 16p12.1-12.2
and 15q13.1-15.1 in the Faroe Island and Druze population
respectively.
SUBJECTS AND METHODS
This study was carried out using the two family sets shown in
fig 1. Informed consent was obtained in accordance with
protocols approved by the University College London Hospital
NHS Trust ethical committee. The diagnosis of affected
subjects was made according to established clinical criteria
9
supported by abnormal ciliary motility studies and electron
microscopy of brushings or biopsy of nasal mucosa.
The Faroe Island resource consisted of seven families
comprising 11 affected and 24 unaffected individuals (fig 1A).
Clinical findings for some of the patients have been described
previously.
19 Only the affected child in UCL140 exhibited
situs inversus. Electron microscopy defined an ultrastructural
phenotype of absent outer dynein arms in Faroe patients
(fig 2B). The patients were Faroese in origin, living on three
of the islands only, except for the father in family UCL140,
who was from Denmark. The families were treated as
unrelated pedigrees in linkage analysis. There was unsup-
ported verbal evidence for distant relatedness between
families UCL96, UCL97, and UCL109, however no formal
genealogical analysis has been possible to establish the
precise relationships. There was one affected parent, the
mother in family UCL98.
Four Druze Israeli families were studied comprising 7
affected and 22 unaffected individuals (Three are shown in
fig 1B). The parents in three families, UCL122, UCL124, and
UCL125, were first cousins, while the fourth family, UCL123,
was non-consanguineous. In contrast to the Faroe Island
population, Druze patients showed an unusually high
incidence of situs inversus (six out of seven affected
children). Electron microscopy defined an ultrastructural
phenotype of partial absence of the inner dynein arms
(fig 2C). Nasal brushings were processed for ultrastructural
studies using established techniques
41 and over 100 suitably
oriented cross sections of cilia throughout the section were
examined to confirm this structural defect. The four families
were located in two neighbouring Druze villages comprising
7500 inhabitants, in the mountainous region of the Golan
Heights. Families UCL122 and UCL124 were from one village
and families UCL123 and UCL125 were from the other.
All of the patients with primary ciliary dyskinesia who
were recognised within the two populations were ascertained
and there is considerable population enrichment for
primary ciliary dyskinesia in both the Faroe Island and
Druze populations. The prevalence of primary ciliary dyski-
nesia in the Faroe Islands is around 1:4500 whilst the local
prevalence amongst the Druze population studied is as high
as 1:1000.
Genome wide scans of 10 cM density were performed in
these two populations using four of the Faroe Island
pedigrees (UCL96, 97, 98, and 109) and all four Druze
pedigrees (UCL122, 123, 124, and 125). Genomic DNA was
extracted from white blood cells using standard methodol-
ogy.
42 Over 350 hundred microsatellite markers from the
Ge ´ne ´thon map
43 were genotyped in each family by polymer-
ase chain reaction and fluorescent based semi-automated
methodology using methods previously described.
24 44 Alleles
were assigned using Genescan and Genotyper software
(Applied Biosystems). Linkage analysis was performed under
the assumption of autosomal recessive inheritance with a
penetrance of 0.9, a disease allele frequency of 0.007 with
equal allele frequencies (0.1) for each marker and a
phenocopy rate of 0.00001. This disease allele frequency
reflects the worldwide incidence of primary ciliary dyskinesia
of 1:20 000. Analysis was also performed using the disease
allele frequencies that reflected more closely the actual
population frequencies we have determined for each popula-
tion as described above: 0.015 for the Faroe Island families
(incidence 1:4500) and 0.03 for the Druze families (incidence
1:1000). Multipoint analyses were performed using the
GENEHUNTER program.
For subsequent fine mapping, six novel microsatellites
were determined in the laboratory from the genomic
sequence of BAC clones spanning the selected region. The
primer pairs used to amplify these polymorphisms were:
59-TGTTTCCTAGACGTGGTCAGC-39/59-ACTTGTACCTTTCAAA
CG-39 (16/4125), 59-TGCAAACAGACTAGGACCAC-39/59-
GGTCTCAAACTCCTGAGCTC-39 (16/10321), 59-CACGCCTGG
CTAGACTAATG-39/59-CTTTACCCAGTGCACATACC-39 (15/14),
59-GTCCCTATGCAACTTTCCAC-39/59-GAATGTGTTTCCCGCTC
TC-39 (15/20), 59-TCTCACCAGAACCGAGAAAG-39/59-
GGTGCCCGCCTATAATCC-39 (15/23) and 59-
GAGTACCACCACTCAATCAAGG-39/59-CTCAGCAGCAGTTGT
TCAAG-39 (15/36).
Haplotypes were manually constructed using the most
parsimonious allele configuration to minimise recombi-
nants. Ge ´ne ´thon marker order and genetic distances were
determined from the deCODE Genetics high resolution
genetic map.
40 Additional markers were positioned in the
deCODE framework map based on their relative position
within the human genome sequence available from the UCSC
Genome Browser, April 2003 Build 33 sequence freeze.
45
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 on 7 April 2005  jmg.bmjjournals.com Downloaded from Figure 1 Pedigrees consistent with linkage on chromosome 16p12.1-12.2 and 15q13.1-15.1. (A) Faroe Island and (B) Druze Israeli haplotypes.
Filled symbols indicate individuals affected with primary ciliary dyskinesia, asterisks indicate patients with situs inversus, and a double line indicates first
cousin marriage. Genetic markers used in the initial genome scan are shown in bold and the box indicates the minimum critical interval encompassing
each locus. For each marker, alleles are coded numerically such that the same allele number correlates to the same allele size across families. The
frameworks of microsatellite markers used were as follows with genetic distances indicated in Kosambi cM: D16S3046, 2.59; D16S3076, 0.003;
D16S403, 0.1; D16S412, 0.5; D16S417, 1.3; UCL420, 0.36; 16/4125, 0.4; 16/10321, 0.16; D16S401, 0.01; D16S3133, 0.31; D16S319, 0.69;
D16S3068, 0.99; D16S3131, 1.55; D16S3093, and D15S975, 2.09; D15S1002, 6.02; D15S1048, 1.57; D15S165, 1.99; D15S1031, 0.22; 15/
14, 1.38; D15S1010, 1.19; 15/20, 0.87; D15S144, 0.57; D15S1007, 1.09; D15S1040, 0.96; 15/23, 0.92; D15S1232, 0.88; D15S971, 0.27;
15/36, 1.12; D15S118, 4.02; D15S1012. Genetic distances were taken from the DeCODE map
39 except for markers 16/4125, 16/10321,
D16S319, 15/14, D15S1010, 15/20, 15/23, D15S1232 and 15/36. These were positioned relative to the DeCODE marker framework using
Human Genome Project draft sequence information as described in the text.
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RESULTS
A region consistent with linkage in the four Faroe Island
families was identified on chromosome 16p12.1-13.1. No
evidence for linkage at any of the known PCD loci was found.
Fine mapping was undertaken in the entire seven family
resource which included the three additional families
UCL135, UCL139, and UCL140. Linkage analysis using
GENEHUNTER was performed across a 9 cM region between
markers D16S3046 and D16S3093. This gave a maximum
multipoint lod score of 3.15 between markers D16S412 and
16/10321. Using a disease allele frequency calculated from the
actual recorded Faroe Island population disease incidence
rather than worldwide incidence of primary ciliary dyskine-
sia, the maximum lod score obtained was 3.13. This is
probably a conservative estimate of the true degree of linkage
as the families were only analysed as unrelated pedigrees.
Haplotype analysis indicated the key recombinant events
defining the critical region on chromosome 16p12.1-12.2
(fig 1A). A paternal recombination in family UCL98 at
D16S403 defined the telomeric limit of the region. The
centromeric limit was defined by a maternal recombination
event in family UCL139 at D16S3133. The D16S403-D16S3133
critical interval spans 2.8 cM which corresponds to a physical
distance of 2.37 Mb.
Although no statistically significant evidence of a common
disease associated haplotype amongst the families could be
proven, three markers in the D16S403-D16S3133 interval did
show a suggestion of linkage disequilibrium with a higher
frequency of certain alleles on disease chromosomes com-
pared to control chromosomes. The control data were taken
from genotypes on the families’ obligate normal chromo-
somes and on chromosomes from a small set of unrelated
Faroe control individuals. The three markers were 16/4125,
D16S401, and D16S3133, with p,0.1 for all three using
Fisher’s exact test. At 16/4125 allele 2 was present on 3/15
(20%) of disease and 1/25 (4%) of control chromosomes;
D16S401 allele 2 was present on 6/15 (40%) of disease and
7/25 (28%) of control chromosomes; and D16S3133 allele 1
was present on 8/15 (53%) disease and 3/13 (23%) of
control chromosomes. All other markers in the entire
D16S3046-D16S3093 interval were non-significant. It was
also noted that the affected child in family UCL98 is
homozygous for the haplotype 3-2-2 at markers 16/4125-16/
10321-D16S401.
Data from one additional Faroe Island pedigree were not
included in the present study. Exclusion from the chromo-
some 16 locus was indicated in this family suggesting the
possibility of locus heterogeneity amongst Faroe Islanders.
However clinical data on the individual who appears to be
recombinant across the region if affected remains incomplete
and the affection status of this individual remains uncertain
at present.
Three out of four of the Druze families were consangui-
neous and a homozygosity mapping approach
46 was used.
Genome scan markers were scored for homozygosity in the
affected individuals in families UCL122, UCL124, UCL125,
and for consistency of linkage in the non-consanguineous
family UCL123. Four regions of excess homozygosity were
identified on chromosomes 1q32, 3p25, 5q33, and 15q13.
Fine mapping using additional markers at each region
resulted in exclusion of all regions except that on chromo-
some 15q13. Linkage analysis using GENEHUNTER across a
25 cM region between markers D15S975 and D15S1012 gave a
maximum multipoint lod score between markers D15S1031
and D15S118 of 3.2 allowing for heterogeneity, at a
(proportion of linked families)=0.73 which suggested that
three out of four families were linked. Using a disease allele
frequency calculated from the actual recorded Druze popula-
tion disease incidence rather than worldwide incidence of
primary ciliary dyskinesia, the maximum lod score obtained
dropped to 3.0. Haplotype analysis confirmed linkage in
families UCL122, UCL123, and UCL125, but not in UCL124.
No evidence for linkage of family UCL124 to any of the
known PCD loci was found. The key recombination events
defining the critical region were determined (fig 1B). The
centromeric and telomeric limits of the region were defined
by loss of homozygosity at D15S1048 in the affected child in
UCL125 and a maternal recombination in family UCL122 at
D15S1012 respectively. The D15S1048-D15S1012 critical inter-
val on chromosome 15q13.1-15.1 spans a region of 17 cM,
corresponding to a physical distance of 9.1 Mb. Interestingly
the non-consanguineous family UCL123 was homozygous by
descent for alleles at the markers D15S1031, 15/14, D15S1010,
15/23, and D15S1232, identifying these as regions of potential
interest if the families harbour a single ancestral mutation.
However the significance is reduced since there was no
evidence of allele sharing amongst affected Druze patients.
DISCUSSION
These results provide statistically significant support for loci
for primary ciliary dyskinesia on chromosomes 16p12.1-12.2
and 15q13.1-15.1. Since primary ciliary dyskinesia is a
genetically and clinically heterogeneous disorder the selec-
tion of patients with an identical ultrastructural phenotype
and families from isolated populations should minimise the
risk of genetic heterogeneity. The incidence of inbreeding is
often high in these populations which may allow the
application of homozygosity or linkage disequilibrium map-
ping to identify and refine the disease gene localisation. This
is a powerful approach
46 and has proved successful in
mapping many autosomal recessive diseases including
Figure 2 Electron micrographs of cross sections of respiratory cilia from patients with primary ciliary dyskinesia. (A) Normal individual with 9+2
microtubule arrangement with intact outer and inner dynein arms. (B) Faroe Island individual with absent outer dynein arm defect. (C) Druze Israeli
individual with partially absent inner dynein arm defect.
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heterogeneity.
24 47 48 This study uses PCD family groups
from two genetically isolated populations from the Faroe
Islands and the Golan Heights Druze community, both of
which were founded and have expanded relatively
recently. There is significant enrichment for primary ciliary
dyskinesia in both these populations presumably due to
isolation and inbreeding, the incidence being around 1:4500
in the Faroe Islands and 1:1000 in the Druze population
studied.
In both populations the initial assumption was that the
existence of single ancestral Faroe Island or Druze mutation
would account for all the patients in each group. However, in
the present study such linkage disequilibrium has not been
detected. At the Faroes locus no common haplotype was
observed among the affected subjects even amongst families
UCL96, UCL97, and UCL109, who may be interrelated, and
the allele sharing observed was not statistically significant.
Identification of linkage disequilibrium by additional marker
typing at both loci would be useful to further refine the
critical interval and pinpoint the localisation of the disease
gene.
The extent of linkage disequilibrium encompassing a
disease gene allele is dependent of course on a number of
factors including natural selection and physical features such
as the local recombination and gene conversion rate.
Population scale effects include the population size, demo-
graphic and admixture history. A large population under
mutation drift equilibrium displays low levels of linkage
disequilibrium while high linkage disequilibrium correlates
with a small population due to genetic drift. If the population
is reduced, then allelic diversity is lowered and genetic drift is
increased. Simulation studies on human populations predicts
that slow early growth, such as that which occurred in the
Faroes population, can be a key factor in increasing the
extent of linkage disequilibrium in an isolated population.
49 50
The age of the disease and marker alleles can be regarded as
one of the most important considerations; the exact timing of
the primary ciliary dyskinesia gene mutation in terms of
when it occurred within the population will influence the
extent to which it has expanded in the population. If the
ancestral mutation is very ancient the region of linkage
disequilibrium may have been eroded by ancient recombina-
tions leaving it extremely small.
We have demonstrated locus heterogeneity in the PCD
Druze families since only three of the four families are linked
to the 15q locus. Moreover the lack of allele sharing suggests
allelic heterogeneity. The intense inbreeding within this
community could allow different mutations on different
haplotypes of a disease gene to expand within the population
giving rise to allelic heterogeneity. It has been suggested that
multiple mutations in a single specific gene in a small
geographic area and in inbred families may in fact be a
common phenomenon.
51 52 Such allelic heterogeneity has
been well described in previous molecular genetic studies in
the Druze population. Three different iduronidase mutations
were found to cause Hurler syndrome in Druze patients from
the Galilee region of Israel
53 and five different mutations in
the arylsulfatase A gene causing metachromatic leucodystro-
phy, occurring on at least three different haplotypes, were
reported in the same region.
54 Two different mutations and
three different genotypes were noted in a small Druze
kindred with Wilson’s disease.
55
Both critical regions on chromosome 16p12.1-12.2 and
15q13.1-15.1 contain no obvious candidate genes based on
known or predicted function or association with axonemal
function. The disease genes may therefore encode proteins
with a novel structural or regulatory role in cilia or flagella,
associated with distinct outer (Faroe Island) and inner
(Druze) dynein arm functions. From published reports and
expressed sequence tag, protein and gene prediction annota-
tion derived from the UCSC Genome Browser, RefSeq, NCBI
Map Viewer, Ensembl transcript and human cDNA collec-
tions,
45 56 the chromosome 16p12.1-12.2 critical region con-
tains 15 distinct genes verified with strong experimental
support, and three predicted genes. Using the same criteria
the chromosome 15q13.1-15.1 critical region contains 25 well
supported genes and 15 predicted genes.
With the identification of two new loci for primary ciliary
dyskinesia, the two candidate intervals defined on chromo-
somes 16p12.1-12.2 and 15q13.1-15.1 provide a framework
for the isolation of the putative genes causing primary ciliary
dyskinesia. The evolutionary conservation of cilia and flagella
structure and function and of the genes encoding axonemal
proteins has previously been used to facilitate isolation of
human PCD genes.
26 27 29 Along with advances in the human
genome project there has been huge progress with the
genome projects for the flagellated PCD model organisms
Chlamydomonas and Trypanosoma.
57–59 Their genome sequence
information and annotation is publicly available (http://
genome.jgi-psf.org/chlre1/chlre1.home.html, http://parsun1.
path.cam.ac.uk/overview.htm) and it is now possible to
incorporate cross species comparative genomics into the
bioinformatics based prioritisation of PCD candidate genes.
Technical advances in genetic manipulation of these model
organisms are also of great potential value, for example for
screening for a flagellar phenotype in mutant Chlamydomonas
and Trypanosoma strains in which the expression of homo-
logues of PCD candidate genes has been ablated by RNA
interference.
60–62
Another postgenomic approach applied to the study of cilia
structure and function is also likely to prove useful in the
search candidate genes for primary ciliary dyskinesia.
Ostrowski and colleagues recently reported results from the
first proteomic analysis of the human ciliary axoneme, aimed
at characterising all the constitutive protein components.
63 In
this study one and two dimensional gel electrophoresis of
cilia from human bronchial epithelial biopsy produced a map
of over 200 putative axonemal proteins, yielding many
potentially novel components of this complex organelle.
Our own bio-informatic analysis has indicated that none of
the available protein sequences from this study correspond
to gene products predicted to map to either the 16p12.1-12.2
or the 15q13.1-15.1 loci. Ciliary actin identified in the
proteomic set does have domain similarity to both a cardiac
specific and a skeletal muscle specific actin isoform located in
the critical region on chromosome 15 but there does not
appear to be a functional correlation. Proteomic studies such
as this have enormous promise and are highly appropriate for
analysis of the cilium. Techniques for more direct analysis of
complex protein mixtures using methods based on mass
spectrometry and the development of protein ‘‘chips’’ are
actively evolving fields which will further advance this
approach.
64
In conclusion, this study reinforces the value of isolated
human populations in gene mapping of heterogenous
disorders. Determining the molecular basis of primary ciliary
dyskinesia will provide insight into the genetic control of cilia
assembly and function and the pathway which determines
the vertebrate left-right axis.
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CORRECTION
doi: 10.1136/jmg.2003.014761corr1
Venturin M, Guarnieri P, Natacci F, et al. Mental retardation and cardiovascular malformations in NF1
microdeleted patients point to candidate genes in 17q11.2 (J Med Genet 2003;41:35–41). We would like to
offer our sincere apologies to the authors of this paper for a number of errors that were introduced
regarding the incorrect use of the term ‘‘learning disability’’. The instances of ‘‘learning disability’’ in the
Key points box, and in Tables 1 and 2 should be ‘‘mental retardation’’. These errors are much regretted
and the corrected versions are shown here.
Table 1 Presence of specific clinical signs in 92 NF1 microdeleted patients v NF1 patients
according to published reports
Clinical signs
NF1 microdeleted patients NF1 patients
Total
evaluable
Total
affected % % Discordance* (x
2 value)
Plexiform neurofibroma 88 25 28 25 to 30 No (0.36 to 0.13)
Macrocephaly 63 20 32 40 to 50 No (1.6 to 6.48)
Facial dysmorphisms  88 69 78 5 to 15 Yes (1065.8 to 264.6)
Hypertelorism 64 27 42 15 Yes (48.60)
Mental retardation 63 36 57 4 to 8 Yes (702 to 300.1)
Seizures 56 5 9 3.8 to 6 No (7.11 to 1.5)
Cardiovascular
malformations` 61 11 18 2.1 Yes (120.39)
Deafness 82 2 2 5.3 No (2.05)
Scoliosis 60 9 15 10 to 30 No (2.5 to 7.5)
Pectus excavatum-carinatum 58 10 17 20 No (0.45)
*The discordant values between the two groups of patients and the relative clinical signs are given in bold.
 Including the following signs, each observed in at least one patient: coarse face, flat occiput/brachycephaly,
facial asymmetry, prominent forehead, frontal bossing, ptosis, downslanting deep set eyes, eversion of the lateral
eyelid, epicanthic folds, strabismus, large nose, prominent nose, high nasal bridge, broad nasal bridge, broad
nose, bulbous nasal tip, large ears, low set ears, malar hypoplasia, wide philtrum, prominent philtrum, small
mouth, thick lips, micrognathia, small pointed chin, low posterior hairline.
`Including: atrial septal defect, ventricular septal defect, patent ductus arteriosus, pulmonary stenosis, dilated aortic
valve, hypertrophic cardiomyopathy, mitral valve prolapse.
Letter to JMG 239
www.jmedgenet.com
 on 7 April 2005  jmg.bmjjournals.com Downloaded from Table 2 Clinical features of the 14 newly described patients carrying NF1 microdeletion characterised by refined fluorescent
in situ hybridisation (FISH) analysis
Patient
Age
(years) Sex Deletion type
Clinical signs
Growth defects Dysmorphic
Mental
retardation
Cardiovascular
malformation Other features
119 4 M REP No No No –
118 5 M cen-REP No No No – Optic glioma, seizures
93 6 M REP 90th centile, macrocephaly Yes* No HCM Broad neck, 3 NFs
65 6 M REP Height 3rd centile,
microcephaly 2nd centile
Yes  IQ48 VSD (upper part) Small hands/feet, short fingers
116 6 M REP Short stature 10th centile Yes` IQ54 Mitral insufficiency MCLS, kyphoscoliosis, pectus
excavatum, genu valgus, pes
planus, umbilical hernia
72 7 M REP No Yes1 IQ50 Small hands/feet, short fingers
76 8 F REP No Yes  No ––
94 8 F REP No Yes** No ––
75 9 F REP No Yes   No ––
85 11 M REP No No IQ77 – MCLS
7 11 M REP No Yes`` Speech
impairment
– MCLS, amblyopia, thalamic
hamartoma
82 23 F REP Short stature No No – Hearing impairment, Noonan-like
77 U F REP Overgrowth .97th centile Yes11 Speech
impairment,
LD
– NFs, required special education,
short and broad fingers and toes
78 U F REP – Yes   Speech
impairment
– Delayed motor development,
short and broad feet, fifth finger
clinodactyly
*Hypertelorism, epicanthic folds, low set ears, low posterior hairline.
 Hypertelorism, downslanting eye, strabismus, large and prominent nose with high and broad bridge, bulbous nasal tip, large and low set ears, malar hypoplasia,
wide and prominent philtrum, small mouth, small pointed chin.
`Hypertelorism, long philtrum, broad nose.
1Prominent forehead, hypertelorism, ptosis (O.DX), downslanting eyes; strabismus, large and prominent nose with high and broad bridge and bulbous nasal tip,
large and low set ears, wide and prominent philtrum, low posterior hairline.
 Coarse face, hypertelorism.
**,  Epicanthic folds.
``Hypertelorism, broad and wild nasal bridge, broad nasal tip.
11Simple facial features.
  Epicanthic folds, bulbous nose, narrow high palate, low forehead.
cen-REP, deletion extending centromerically to REP-P; CVM, cardiovascular malformations; F, female; HCM, hypertrophic cardiomyopathy; LD, learning
disabilities; M, male; MCLS, multiple cafe `-au-lait spots; NF, neurofibroma; REP, NF1 repeat mediated deletion; U, unknown; VSD, ventricular septal defect.
Key points
N NF1 microdeletion syndrome is determined by haplo-
insufficiency of the NF1 gene and its flanking regions;
NF1 microdeleted patients show a more severe
phenotype than observed in classical NF1 patients.
N The aim of this study was to verify the presence of
specific clinical signs of NF1 microdeletion, by
combining clinical and genetic evidence from 92
deleted patients, 14 newly characterised and 78
already published.
N Statistical analysis, done by comparing the frequency
of 10 clinical signs between NF1 microdeleted patients
and the whole NF1 population, showed that the most
common extra-NF1 clinical signs in microdeleted
patients were mental retardation, cardiovascular mal-
formations, and dysmorphisms.
N Using bioinformatic tools, the deletion gene content of
44 genetically and clinically characterised patients was
established. It is proposed that haploinsufficiency of
OMG and/or CDK5R1 genes may be implicated in
mental retardation. In relation to cardiovascular
malformations, only JJAZ1 and CENTA2 can be
considered as plausible candidate genes.
N When present in an NF1 patient, dysmorphisms,
cardiac anomalies, and mental retardation are signs
indicating NF1 microdeletion.
CORRECTION
doi: 10.1136/jmg.2003.008433corr
Owing to the change over of typesetters at the
BMJ Publishing Group Ltd last year, we
would like to apologise for an error that
was published in the paper by Baser et al (J
Med Genet 2003;40:758–760). In Table 2 the
headings ‘Classical NF2’ and ‘Somatic
mosaic’ should be indented as they are sub-
sections of the heading ‘Nonsense or frame-
shift’.
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